Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite
- PMID: 17118654
- DOI: 10.1016/j.bmcl.2006.10.084
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite
Abstract
Hydroxylated derivatives were designed and synthesized based on the information of oxidative metabolites. Compounds derived from beta-substituted (2R,3R)-2-amino-3-hydroxypropionic acid showed improved inhibitory activities against the binding of MIP-1alpha to human CCR5, compared with the non-hydroxylated derivatives and the other isomers.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical